K R Webster-Kerr1, Cdc Christie2, A Grant3, D Chin3, H Burrowes3, K Clarke3, I Wellington3, K Shaw3, W De La Haye3. 1. Ministry of Health, Kingston, Jamaica. E-mail: websterk@moh.gov.jm; kwebsterkerr@yahoo.com. 2. Department of Child and Adolescent Health, The University of the West Indies, Mona, Kingston 7, Jamaica. 3. Ministry of Health, Kingston, Jamaica.
Abstract
BACKGROUND: Jamaica, along with the Americas, experienced major epidemics of arboviral diseases transmitted by the Aedes aegypti mosquito in recent years. These include dengue fever in 2012, Chikungunya fever in 2014 and Zika virus infection (ZIKV) in 2016. We present the emergence of the ZIKV epidemic in Jamaica and outline the national response. METHODS: The Ministry of Health's preparedness included: heightened surveillance, clinical management guidance, vector control and management, laboratory capacity strengthening, training and staffing, risk communication and public education, social mobilization, inter-sectoral collaboration, resource mobilization and international cooperation. RESULTS: The first case of ZIKV was confirmed on January 29, 2016 with date of onset of January 17, 2016. From January 3 to July 30, 2016 (Epidemiological Week (EW) 1-30), 4648 cases of ZIKV were recorded (4576 suspected, 72 laboratory-confirmed). Leading symptoms were similar among suspected and confirmed cases: rash (71% and 88%), fever (65% and 53%) and joint pains (47% and 38%). There were 17 suspected cases of Guillain Barre syndrome; 383 were reported in pregnant women, with no reports of microcephaly to date. Zika and dengue viruses were circulating predominantly in 2016. At EW30, 1744 cases of dengue were recorded (1661 suspected and 83 confirmed). Dengue serotypes 3 and 4 were circulating with 121 reports of dengue haemorrhagic fever. CONCLUSION: The possibility exists for endemicity of ZIKV similar to dengue and chikungunya in Jamaica. A ZIKV vaccine, similar to the dengue and chikungunya vaccines, is needed to be fast-tracked into clinical trials to mitigate the effects of this disease.
BACKGROUND: Jamaica, along with the Americas, experienced major epidemics of arboviral diseases transmitted by the Aedes aegypti mosquito in recent years. These include dengue fever in 2012, Chikungunya fever in 2014 and Zika virus infection (ZIKV) in 2016. We present the emergence of the ZIKV epidemic in Jamaica and outline the national response. METHODS: The Ministry of Health's preparedness included: heightened surveillance, clinical management guidance, vector control and management, laboratory capacity strengthening, training and staffing, risk communication and public education, social mobilization, inter-sectoral collaboration, resource mobilization and international cooperation. RESULTS: The first case of ZIKV was confirmed on January 29, 2016 with date of onset of January 17, 2016. From January 3 to July 30, 2016 (Epidemiological Week (EW) 1-30), 4648 cases of ZIKV were recorded (4576 suspected, 72 laboratory-confirmed). Leading symptoms were similar among suspected and confirmed cases: rash (71% and 88%), fever (65% and 53%) and joint pains (47% and 38%). There were 17 suspected cases of Guillain Barre syndrome; 383 were reported in pregnant women, with no reports of microcephaly to date. Zika and dengue viruses were circulating predominantly in 2016. At EW30, 1744 cases of dengue were recorded (1661 suspected and 83 confirmed). Dengue serotypes 3 and 4 were circulating with 121 reports of dengue haemorrhagic fever. CONCLUSION: The possibility exists for endemicity of ZIKV similar to dengue and chikungunya in Jamaica. A ZIKV vaccine, similar to the dengue and chikungunya vaccines, is needed to be fast-tracked into clinical trials to mitigate the effects of this disease.
Authors: Joshua J Anzinger; Chadwic D Mears; A E Ades; Keisha Francis; Yakima Phillips; Ynolde E Leys; Moira J Spyer; David Brown; Ana M Bispo de Filippis; Eleni Nastouli; Thomas Byrne; Heather Bailey; Paulette Palmer; Lenroy Bryan; Karen Webster-Kerr; Carlo Giaquinto; Claire Thorne; Celia D C Christie Journal: Emerg Infect Dis Date: 2022-02 Impact factor: 6.883
Authors: Sheena Francis; Chelsea Frank; Luke Buchanan; Sean Green; Roxann Stennett-Brown; Georgiana Gordon-Strachan; Yasmin Rubio-Palis; Charles Grant; Ruby Lisa Alexander-Lindo; Chukwuemeka Nwokocha; Dwight Robinson; Rupika Delgoda Journal: One Health Date: 2021-08-24
Authors: Aileen May Lue; Michelle-Ann Elizabeth Hue Richards-Dawson; Georgiana Marie Gordon-Strachan; Syed Matthew Kodilinye; Jacqueline Anne Theresa Dunkley-Thompson; Tracia Dahlia James-Powell; Curtis Alphonso Pryce; Chadwic De'sean Mears; Joshua James Anzinger; Karen Webster-Kerr; Celia Dana Claire Christie Journal: Front Med (Lausanne) Date: 2022-06-21
Authors: Elisa Ruiz-Burga; Patricia Bruijning-Verhagen; Paulette Palmer; Annalisa Sandcroft; Georgina Fernandes; Marieke de Hoog; Lenroy Bryan; Russell Pierre; Heather Bailey; Carlo Giaquinto; Claire Thorne; Celia D C Christie Journal: JMIR Form Res Date: 2022-07-27